Merck & Company Inc (MRK) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Merck & Co., Inc. operates as a healthcare company worldwide.
Total Assets Chart for Merck & Company Inc
Merck & Company Inc (MRK) total assets for FY2025 were USD 136.9B, a 16.9% change from FY2024. Merck & Company Inc's total assets grew from USD 4.9B in 1985 to USD 136.9B in 2025 (2691.9% over 40 years). Total assets compound annual growth rate: 5-year CAGR of 8.4%, 10-year CAGR of 3.0%, 20-year CAGR of 5.7%.
Total Assets (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $335.14B
- Implied Share Price
- $135.84
- Enterprise Value
- $381.91B
- Revenue (TTM)
- $66.57B
- EBITDA
- $28.87B
- Profit Margin
- 4.77%
- Trailing P/E
- 108.67
- Forward P/E
- 49.51
- Price/Book (MRQ)
- 7.99
- Price/Sales (TTM)
- 5.03
- EV/EBITDA
- 26.51
- EV/Revenue
- 5.74
- Dividend Yield
- 2.45%
- Book Value
- $16.99
- Free Cash Flow (FY2025)
- $12.36B
- Free Cash Flow Yield
- 3.69%
Snapshot as of 16th August 2026 — not point-in-time controlled, may lag the live market by a few days.